Evidence map›Paper›PMID 20144926›Full record

Trial reportRheumatology (Oxford, England)2010

Tendon friction rubs in early diffuse systemic sclerosis: prevalence, characteristics and longitudinal changes in a randomized controlled trial.

Puja P Khanna, Daniel E Furst, Philip J Clements, Paul Maranian, Lilavati Indulkar, Dinesh Khanna, D-Penicillamine Investigators

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Rheumatology (Oxford, England), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 62 citations in OpenAlex.

  1. Assessment of skin involvement in systemic sclerosis.Rheumatology (Oxford, England) · 2017
    Pooled it
  2. Review
  3. Article
  4. Review
  5. Musculoskeletal ultrasound of the shoulder in systemic sclerosis.Journal of scleroderma and related disorders · 2022
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Management of Musculoskeletal Involvement in Systemic Sclerosis.Current treatment options in rheumatology · 2016
    Article
  13. Management of Widespread Skin Thickening in Diffuse Systemic Sclerosis.Current treatment options in rheumatology · 2016
    Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Article
  20. Diffuse palpable tendon friction rubs in a patient with seronegative erosive polyarthritis.Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Puja P KhannaDepartment of Medicine, Division of Rheumatology, David Geffen School of Medicine, UCLA, Los Angeles, CA 90095, USA. dkhanna@mednet.ucla.edu
Daniel E Furst
Philip J Clements
Paul Maranian
Lilavati Indulkar
Dinesh Khanna
D-Penicillamine Investigators
University of California, Los Angeles · US

Funding

Academic Training in RheumatologyT32AR053463 · NIAMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SINGH, RAM RAJ · 2007 to 2011
$1.1M
Health Values and Minimally Important Differences in Systemic SclerosisK23AR053858 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KHANNA, DINESH · 2007 to 2011
$617k
NIAMS NIH HHS 1 T32 AR053463NIAMS NIH HHS K23 AR053858NIAMS NIH HHS K23 AR053858-03NIAMS NIH HHS T32 AR053463
6 · The paper itself

Abstract

objectivesTo characterize the baseline tendon friction rubs (TFRs) in early dcSSc and to evaluate the association of change in TFR over 6 and 12 months with changes in modified Rodnan skin score (MRSS) and HAQ-Disability Index (HAQ-DI) over 12 and 24 months, respectively.

methodsWe analysed data from the d-Pen study, a 2-year study in early dcSSc (< or =18 months from first non-Raynaud's symptom). TFR was scored as present/absent at seven anatomical sites at baseline and every 6 months thereafter. Multivariable linear regression models assessed associations between TFR and change in MRSS, and change in the HAQ-DI, over 12 and 24 months, respectively. Covariates included baseline TFR, change in the TFR over 6 and 12 months, age, sex, duration of SSc, MRSS, and tender joint count and swollen joint count (SJC).

resultsForty-nine (37%) of 134 patients had TFR at baseline, 50% had resolution of their TFR, whereas 21% developed new TFRs. Patients with baseline TFRs were likely to be Caucasian (86 vs 58%) and had a higher HAQ-DI score (P = 0.008). In regression analyses, change in TFR (P = 0.04) and baseline MRSS (P = 0.03) predicted change in MRSS over a 12-month period (Model R(2 )= 0.14). For the HAQ-DI model, independent predictors were change in TFR at 6 months (P = 0.008) and baseline SJC (P = 0.04, Model R(2 )= 0.19). Results were similar for 24-month models.

conclusionsWe document the presence of TFR very early in the course of dcSSc. Changes in TFR over 6 and 12 months predict changes in MRSS and HAQ-DI over 12 and 24 months, respectively.

Indexed as

AdultDisability EvaluationDisease ProgressionFemaleFrictionHumansMaleMiddle AgedPredictive Value of TestsPrevalenceRegression AnalysisScleroderma, DiffuseScleroderma, SystemicTendonsTime Factors

Identifiers

PMID20144926
PMCPMC2909791
OpenAlexW2134420763

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.